Elli Peselev

Array ( [id] => 5149571 [patent_doc_number] => 20070049631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Ectoparasiticidal formulations of spinosyms and azole pesticides' [patent_app_type] => utility [patent_app_number] => 10/577232 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4165 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049631.pdf [firstpage_image] =>[orig_patent_app_number] => 10577232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023497 [patent_doc_number] => 20070149463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Bifunctional macrolide heterocyclic compounds and methods of making and using the same' [patent_app_type] => utility [patent_app_number] => 10/577903 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18644 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149463.pdf [firstpage_image] =>[orig_patent_app_number] => 10577903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959240 [patent_doc_number] => 20050215490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Polyene polyketides and methods of treating bacterial infections' [patent_app_type] => utility [patent_app_number] => 10/975545 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14640 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215490.pdf [firstpage_image] =>[orig_patent_app_number] => 10975545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411685 [patent_doc_number] => 07282487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Method for treating bacterial infections in horses or pigs with tilmicosin' [patent_app_type] => utility [patent_app_number] => 10/974877 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7981 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282487.pdf [firstpage_image] =>[orig_patent_app_number] => 10974877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997363 [patent_doc_number] => 20050137141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Prodrug composition' [patent_app_type] => utility [patent_app_number] => 10/972729 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7314 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137141.pdf [firstpage_image] =>[orig_patent_app_number] => 10972729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193540 [patent_doc_number] => 20070082024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Tyrosinase activity inhibitor and ameliorant for facial blood flow' [patent_app_type] => utility [patent_app_number] => 10/577135 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4606 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082024.pdf [firstpage_image] =>[orig_patent_app_number] => 10577135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057611 [patent_doc_number] => 20070060533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/576350 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4937 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060533.pdf [firstpage_image] =>[orig_patent_app_number] => 10576350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083825 [patent_doc_number] => 20050049205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 10/962664 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7240 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049205.pdf [firstpage_image] =>[orig_patent_app_number] => 10962664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931724 [patent_doc_number] => 20050282759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Injectable ready-to-use solutions containing an antitumor anthracycline glycoside' [patent_app_type] => utility [patent_app_number] => 10/963476 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11678 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282759.pdf [firstpage_image] =>[orig_patent_app_number] => 10963476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638069 [patent_doc_number] => 20060069043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Chiral separation, characterization and biological action of optically active isomers of digoxin' [patent_app_type] => utility [patent_app_number] => 10/951900 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5576 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069043.pdf [firstpage_image] =>[orig_patent_app_number] => 10951900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172381 [patent_doc_number] => 20070072814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Method and means of modulating lipid metabolism' [patent_app_type] => utility [patent_app_number] => 10/574852 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3663 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072814.pdf [firstpage_image] =>[orig_patent_app_number] => 10574852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 418815 [patent_doc_number] => 07276487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => '9a, 11-3C-bicyclic 9a-azalide derivatives' [patent_app_type] => utility [patent_app_number] => 10/946339 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22649 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276487.pdf [firstpage_image] =>[orig_patent_app_number] => 10946339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000337 [patent_doc_number] => 20070042971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Crystalline compound of 4\'-demethyl-4\'-phosphate-2\", 3\"-bispentafluorophenoxy-acetyl-4\", 6\"-ethylidene-beta-d-epipodophyllotoxin glucoside either in its free form or solvated with ethanol' [patent_app_type] => utility [patent_app_number] => 10/572061 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5082 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042971.pdf [firstpage_image] =>[orig_patent_app_number] => 10572061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098455 [patent_doc_number] => 20050130914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Methods of administering dalbavancin for treatment of skin and soft tissue infections' [patent_app_type] => utility [patent_app_number] => 10/942604 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23004 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130914.pdf [firstpage_image] =>[orig_patent_app_number] => 10942604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034211 [patent_doc_number] => 20050032721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Methods of administering dalbavancin for treatment of skin and soft tissue infections' [patent_app_type] => utility [patent_app_number] => 10/942197 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22968 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032721.pdf [firstpage_image] =>[orig_patent_app_number] => 10942197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906153 [patent_doc_number] => 20050101548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Antimicrobial derivatives' [patent_app_type] => utility [patent_app_number] => 10/940900 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17550 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101548.pdf [firstpage_image] =>[orig_patent_app_number] => 10940900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977577 [patent_doc_number] => 08071535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Guanidinium derivatives for improved cellular transport' [patent_app_type] => utility [patent_app_number] => 10/571510 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13487 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071535.pdf [firstpage_image] =>[orig_patent_app_number] => 10571510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390325 [patent_doc_number] => 07300921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Polyene polyketides and methods of production' [patent_app_type] => utility [patent_app_number] => 10/937379 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 31412 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300921.pdf [firstpage_image] =>[orig_patent_app_number] => 10937379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085860 [patent_doc_number] => 20070275911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same' [patent_app_type] => utility [patent_app_number] => 10/570471 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 65600 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275911.pdf [firstpage_image] =>[orig_patent_app_number] => 10570471 [rel_patent_id] =>[rel_patent_doc_number] =>)